CRISPR cancer trial success paves the way for personalized treatments.
Nature, 611(7936): 433-434 PMID 36357583 DOI 10.1038/d41586-022-03676-7
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.